Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.52B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
ProShares UltraPro QQQ
TQQQ
|
+$555M |
| 4 |
Dell
DELL
|
+$542M |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.18B |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.29B |
| 3 |
Visa
V
|
+$1.12B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$918M |
| 5 |
Broadcom
AVGO
|
+$892M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.93% |
| 2 | Consumer Discretionary | 1.52% |
| 3 | Healthcare | 0.84% |
| 4 | Financials | 0.83% |
| 5 | Communication Services | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8701
CALL
uniQure
QURE
$3.21B
| $167K | ﹤0.01% |
33,900
+19,100
| +129% | +$124K |
|
8702
OptimizeRx
OPRX
$129M
| $167K | ﹤0.01% |
21,646
-12,682
| -37% | -$113K |
|
8703
HighPeak Energy
HPK
$1B
| $167K | ﹤0.01% |
12,035
-37,491
| -76% | -$572K |
|
8704
CALL
SSR Mining
SSRM
$6.41B
| $167K | ﹤0.01% |
29,400
-4,200
| -13% | -$22K |
|
|
NAGE
8705
Niagen Bioscience
NAGE
$238M
| $167K | ﹤0.01% |
45,712
+22,889
| +100% | +$72K |
|
8706
PennantPark Floating Rate Capital
PFLT
$726M
| $167K | ﹤0.01% |
14,417
-15,240
| -51% | -$173K |
|
8707
X4 Pharmaceuticals
XFOR
$428M
| $166K | ﹤0.01% |
8,282
+4,210
| +103% | +$87.9K |
|
|
AGNT
8708
CALL
AGNT Inc
AGNT
$697M
| $166K | ﹤0.01% |
+11,800
| New | +$152K |
|
8709
CALL
Ocular Therapeutix
OCUL
$2.02B
| $166K | ﹤0.01% |
+19,100
| New | +$157K |
|
8710
PUT
Teucrium Wheat Fund
WEAT
$294M
| $166K | ﹤0.01% |
6,340
-3,200
| -34% | -$81.4K |
|
|
MGIC
8711
DELISTED
Magic Software Enterprises
MGIC
| $166K | ﹤0.01% |
14,038
-14,885
| -51% | -$162K |
|
8712
Ultralife
ULBI
$112M
| $166K | ﹤0.01% |
+18,322
| New | +$189K |
|
8713
CALL
POET Technologies
POET
$1.48B
| $166K | ﹤0.01% |
+37,300
| New | +$116K |
|
|
ADAP
8714
DELISTED
Adaptimmune Therapeutics
ADAP
| $166K | ﹤0.01% |
174,157
+98,581
| +130% | +$112K |
|
8715
Luxfer Holdings
LXFR
$457M
| $165K | ﹤0.01% |
12,771
-27,170
| -68% | -$316K |
|
8716
Sprott Lithium Miners ETF
LITP
$41M
| $165K | ﹤0.01% |
20,113
+3,625
| +22% | +$26.6K |
|
|
SFIX
8717
CALL
Stitch Fix
SFIX
$543M
| $165K | ﹤0.01% |
+58,400
| New | +$227K |
|
8718
Viemed Healthcare
VMD
$360M
| $164K | ﹤0.01% |
22,356
-69,320
| -76% | -$495K |
|
8719
Akebia Therapeutics
AKBA
$237M
| $163K | ﹤0.01% |
123,728
-2,766
| -2% | -$3.69K |
|
8720
Universal Electronics
UEIC
$72.3M
| $163K | ﹤0.01% |
+17,678
| New | +$178K |
|
8721
Annovis Bio
ANVS
$79.1M
| $163K | ﹤0.01% |
20,206
+10,083
| +100% | +$94.5K |
|
8722
Black Stone Minerals
BSM
$3.04B
| $163K | ﹤0.01% |
10,783
-131,747
| -92% | -$1.97M |
|
8723
BARK
BARK
$99.7M
| $162K | ﹤0.01% |
4,971
-4,567
| -48% | -$149K |
|
|
AVDL
8724
PUT
DELISTED
Avadel Pharmaceuticals
AVDL
| $161K | ﹤0.01% |
+12,300
| New | +$187K |
|
8725
Energy Vault
NRGV
$620M
| $161K | ﹤0.01% |
167,806
-166,264
| -50% | -$167K |
|
Similar funds
Jane Street's Q3 2024 Portfolio in Review
As of Q3 2024, Jane Street held 10,828 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Jane Street withdrew a net $18.5B in Q3 2024, closing 1,349 positions and reducing 4,327 holdings. Its most notable exit was iShares Core MSCI International Developed Markets ETF, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.9% of assets, down from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jane Street opened a new position in Schwab Short-Term US Treasury ETF worth $424M.
- Jane Street's largest Q3 2024 buy was Schwab Short-Term US Treasury ETF: 17,304,274 shares worth $424M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.52B increase.
- Jane Street's biggest Q3 2024 reduction was Apple, cutting an estimated $4.18B.
- Jane Street fully exited iShares Core MSCI International Developed Markets ETF in Q3 2024, selling an estimated $290M.
- Jane Street's ten largest holdings make up 44% of its $453B portfolio in Q3 2024.
- Jane Street opened 1,593 new positions and closed 1,349 in Q3 2024.
- Jane Street's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.